# InTRist (NCT05888402)

> Induction Chemotherapy and Toripalimab Followed by Chemoradiotherapy for Large-volume Local Advanced NSCLC

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT05888402
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Conditions: Local Advanced Non-small Cell Lung Cancer
- Interventions: Toripalimab; Concurrent chemoradiation therapy and consolidation immunotherapy
- Enrollment: 50
- Primary outcome: Progression-free survival (PFS)

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 33

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=intrist-nct05888402

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT05888402", "email": "<work email>"}; the inbox owner confirms by the emailed link.